Keywords: tracleer, approved, eu, pah, fc, ii, actelion

Tracleer approved in EU for PAH FC II

Article | 11 August 2008

Actelion's Tracleer (bosentan) has been approved in the European Union for the treatment of patients with mildly symptomatic pulmonary arterial ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

bosentan

Tracleer

Go to drug listing